This systematic review and meta-analysis aimed to evaluate the efficacy of surgical management, specifically total and partial tonsillectomy, for Periodic Fever, Aphthous Stomatitis, Pharyngitis, and Cervical Adenitis (PFAPA) syndrome, focusing on symptom resolution and recurrence reduction. A systematic search of MEDLINE, Scopus, and Cochrane databases identified randomized controlled trials (RCTs) comparing surgical to non-surgical management in children with PFAPA. Data extraction and quality assessment adhered to Cochrane guidelines and PRISMA protocols. Risk ratios (RR) and confidence intervals (CI) were calculated using random-effects models. After the removal of duplicates, 31 studies were screened and 3 studies were included. Pooled analysis revealed a 72% reduction in persistent symptoms following surgical interventions compared to non-surgical management (RR: 0.28, 95% CI: 0.12-0.68, I² = 22%, p = 0.005). The findings confirm that surgical management, including total and partial tonsillectomy, is an effective therapeutic option for PFAPA, with substantial benefits in symptom resolution and quality of life improvement. While surgery offers long-term benefits, its risks, and broader immunological implications require careful consideration. The study underscores the necessity for larger, multicenter trials to validate these findings across diverse populations and optimize treatment strategies.
Tranexamic acid (TXA) is an antifibrinolytic agent with demonstrated benefits in various surgical procedures, including urological surgeries. However, its
1 January 2026 in Revista do Colégio Brasileiro de Cirurgiões
Introduction: While the conservative management of blunt liver injuries is well established in the medical literature, with reported success rates ranging from 82% to 100% in hemodynamically stable patients, its application to penetrating injuries remains controversial due to perceived risks. This study aims to assess the potential outcomes of non-operative management (NOM) in selected patients with penetrating liver injuries compared to operative management (OM). Methods: A systematic review and meta-analysis of observational studies comparing NOM and OM in patients with penetrating liver injuries was conducted using the Medline, Scopus, and Cochrane databases, in accordance with the Cochrane Handbook for Systematic Reviews of Interventions and the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA). Results: Six observational studies comprising 4,407 patients were included. NOM was associated with lower mortality (RR 0.40; 95% CI 0.31-0.53; I2=0%; p<0.01) and complication rates (RR 0.83; 95% CI 0.75-0.91; I2=0%; p<0.01). No statistically significant difference was observed in liver complications (RR 0.25; 95% CI 0.01-12.47; I2=0%; p=0.10), blood transfusion (RR 0.73; 95% CI 0.0-1741.82; I2=84%; p=0.73), and hospital length of stay (RR -0.44; 95% CI -6.76-5.87; I2=0%; p=0.83). Conclusion: Non-operative management of penetrating liver injuries, when compared to operative management, may be considered a possible alternative for selected patients.
1 January 2026 in Revista do Colégio Brasileiro de Cirurgiões
RESUMO Introdução: Embora o tratamento conservador de lesões hepáticas contusas esteja bem estabelecido na literatura médica, com taxas de sucesso relatadas variando de 82% a 100% em pacientes hemodinamicamente estáveis, sua aplicação em lesões penetrantes permanece controversa devido às potenciais complicações. Este estudo tem como objetivo avaliar os desfechos do tratamento não operatório (TNO) em pacientes selecionados com lesões hepáticas penetrantes, em comparação ao tratamento operatório (TO). Métodos: Uma revisão sistemática e meta-análise de estudos observacionais comparando TNO e TO em pacientes com lesões hepáticas penetrantes foi conduzida por meio dos bancos de dados Pubmed, Scopus e Cochrane de acordo com o Guia Cochrane para Revisões Sistemáticas e Meta-análises e Itens de Relato Preferenciais para Revisões Sistemáticas e Meta-Análises (PRISMA). Resultados: Foram abordados seis estudos observacionais que incluíram 4.407 pacientes. O TNO foi associado a menor mortalidade (RR 0.40; 95% CI 0.31-0.53; I2=0%; p<0.01) e menores taxas de complicação (RR 0.83; 95% CI 0.75-0.91; I2=0%; p<0.01). Não foi observada diferença estatisticamente significativa nas taxas de complicações hepáticas (RR 0.25; 95% CI 0.01-12.47; I2=0%; p=0.10), nas taxas de transfusão sanguínea (RR 0.73; 95% CI 0.0-1741.82; I2=84%; p=0.73) e na duração da internação hospitalar (RR -0.44; 95% CI -6.76-5.87; I2=0%; p=0.83). Conclusão: O TNO de lesões hepáticas penetrantes, quando comparado ao TO, pode ser considerado uma alternativa possível para pacientes selecionados.